ArticleThoracic cancer2019

Re-biopsy and liquid biopsy for patients with non-small cell lung cancer after EGFR-tyrosine kinase inhibitor failure.

Juan Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.